PT  - JOURNAL ARTICLE
AU  - John A. Morris
AU  - Jahan A. Rahman
AU  - Xinyi Guo
AU  - Neville E. Sanjana
TI  - Automated design of CRISPR prime editors for thousands of human pathogenic variants
AID  - 10.1101/2020.05.07.083444
DP  - 2020 Jan 01
TA  - bioRxiv
PG  - 2020.05.07.083444
4099  - http://biorxiv.org/content/early/2020/05/09/2020.05.07.083444.short
4100  - http://biorxiv.org/content/early/2020/05/09/2020.05.07.083444.full
AB  - Prime editors (PEs) are CRISPR-based genome engineering tools that can introduce precise base-pair edits at specific locations in the genome. These programmable gene editors have been predicted to repair 89% of known human pathogenic variants in the ClinVar database, although these PE constructs do not presently exist. Towards this end, we developed an automated pipeline to correct (therapeutic editing) or introduce (disease modeling) human pathogenic variants that optimizes the design of several RNA constructs required for prime editing and avoids predicted off-targets in the human genome. However, using optimal PE design criteria, we find that only a small fraction of these pathogenic variants can be targeted. Through the use of alternative Cas9 enzymes and extended templates, we increase the number of targetable pathogenic variants to >50,000 variants and make these pre-designed PE constructs accessible through a web-based portal (http://primeedit.nygenome.org). Given the tremendous potential for therapeutic gene editing, we also assessed the possibility of developing universal PE constructs. By examining the overlap of different PE components with common human genetic variants in dbSNP, we find that common variants affect only a small minority of designed PEs.Competing Interest StatementThe authors have declared no competing interest.